Make Informed Investment Decisions with Affordable Access to Experts
Checking in on Belbuca's launch: A follow-up visit with our expert from April 4th 2016Ticker(s): BDSI, ENDP, COLL
Institution: Duke University
- Associate Professor of Anesthesiology and Director of Interventional Pain.
- Extensive research experience performing both investigator-initiated and industry sponsored studies, has led two clinical trials that examined the efficacy of pain medicine in surgical and non-surgical patient.
- Expert on current standards for opioid management; has authored numerous articles in peer reviewed journals.
How many patients do you currently manage pain for?Added By: joe_mccann
What's your high level view of Belbuca now that you have had a few months to prescribe it?Added By: joe_mccann
How many patients have you prescribed Belbuca? How does this align with your expectations in April?Added By: joe_mccann
What are present and emerging alternatives to Belbuca, and how might Belbuca stack up?Added By: rocks3
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.